Literature DB >> 14980339

Acute, transient urinary retention from combined ecstasy and methamphetamine use.

João H Delgado1, Michael J Caruso, Javier C Waksman, Benjamin Honigman, Dan Stillman.   

Abstract

Methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") are synthetic amphetamine analogs that have become increasingly popular, particularly among adolescents and young adults. Many deleterious physiologic effects arising from the use of these agents have been well documented in the medical literature. Urinary retention, however, has rarely been reported as an effect of MDMA or methamphetamine use and is thought to occur as a result of alpha-adrenoceptor stimulation of the bladder neck. We report a case of acute, transient urinary retention due to combined MDMA and methamphetamine use with laboratory confirmation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980339     DOI: 10.1016/j.jemermed.2003.05.007

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  5 in total

Review 1.  Updates of underactive bladder: a review of the recent literature.

Authors:  Xing Li; Limin Liao
Journal:  Int Urol Nephrol       Date:  2016-03-01       Impact factor: 2.370

Review 2.  Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.

Authors:  Aryan Sarparast; Kelan Thomas; Benjamin Malcolm; Christopher S Stauffer
Journal:  Psychopharmacology (Berl)       Date:  2022-03-07       Impact factor: 4.415

3.  Neurogenic bladder and chronic urinary retention associated with MDMA abuse.

Authors:  John R Beuerle; Fermin Barrueto
Journal:  J Med Toxicol       Date:  2008-06

Review 4.  Urological complications of illicit drug use.

Authors:  Sean C Skeldon; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

5.  Investigation of urinary components in rat model of ketamine-induced bladder fibrosis based on metabolomics.

Authors:  Haozhen Li; Quan Zhu; Kaixuan Li; Ziqiang Wu; Zhengyan Tang; Zhao Wang
Journal:  Transl Androl Urol       Date:  2021-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.